Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): an updated review

J Dong, L Yuan, C Hu, X Cheng, JJ Qin - Pharmacology & Therapeutics, 2023 - Elsevier
The emergence of multidrug resistance (MDR) in malignant tumors is one of the leading
threats encountered currently in many chemotherapeutic agents. The overexpression of the …

[HTML][HTML] Vincristine in combination therapy of cancer: emerging trends in clinics

J Škubník, VS Pavlíčková, T Ruml, S Rimpelová - Biology, 2021 - mdpi.com
Simple Summary Vincristine is a vinca alkaloid naturally occurring in Catharanthus roseus. It
belongs to antimitotic compounds, which arrest the cell cycle via disrupting microtubule …

[HTML][HTML] Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein

Y Tian, Y Lei, Y Wang, J Lai… - … Journal of Oncology, 2023 - spandidos-publications.com
Multidrug resistance (MDR) seriously limits the clinical application of chemotherapy. A
mechanism underlying MDR is the overexpression of efflux transporters associated with …

Molecular modeling strategies of cancer multidrug resistance

G Yalcin-Ozkat - Drug Resistance Updates, 2021 - Elsevier
Cancer remains a leading cause of morbidity and mortality worldwide. Hence, the increase
in cancer cases observed in the elderly population, as well as in children and adolescents …

Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell

Z Yang, X Yang, Y Li, Y Cai, Y Yu, W Zhuang… - European Journal of …, 2023 - Elsevier
The co-administration of anticancer drugs and P-glycoprotein (P-gp) inhibitors was a
treatment strategy to surmount multidrug resistance (MDR) in anticancer chemotherapy. In …

Simplified derivatives of tetrandrine as potent and specific P-gp inhibitors to reverse multidrug resistance in cancer chemotherapy

R Zeng, XM Yang, HW Li, X Li, Y Guan… - Journal of Medicinal …, 2023 - ACS Publications
Targeted inhibition of a drug efflux transporter P-glycoprotein (P-gp) is an important strategy
to reverse multidrug resistance in cancer chemotherapy. In this study, a rationally structural …

Modular biomimetic strategy enabled discovery of simplified pseudo-natural macrocyclic P-glycoprotein inhibitors capable of overcoming multidrug resistance

B Liu, X Yu, L Liu, L Wang, J Wang… - Journal of Medicinal …, 2023 - ACS Publications
Natural macrocycles have shown impressive activity to overcome P-glycoprotein (P-gp)-
mediated multidrug resistance (MDR). However, the total synthesis and structural …

Novel benzo five-membered heterocycle derivatives as P-glycoprotein inhibitors: design, synthesis, molecular docking, and anti-multidrug resistance activity

Z Yang, Y Cai, X Yang, Y Li, Q Wu, Y Yu… - Journal of Medicinal …, 2023 - ACS Publications
A proposed strategy to overcome multidrug resistance (MDR) of anticancer drugs in
chemotherapy is to disable the efflux function of P-glycoprotein (P-gp). In this study, based …

Discovery of benzochromene derivatives first example with dual cytotoxic activity against the resistant cancer cell MCF-7/ADR and inhibitory effect of the P …

LM Al-Harbi, EA Al-Harbi, RM Okasha… - Journal of enzyme …, 2023 - Taylor & Francis
A series of 1 H-benzo [f] chromene moieties (4a–z) were synthesised under Ultrasonic
irradiation and confirmed with spectral analyses. Derivative 4i solely possessed an X-ray …

Discovery of (quinazolin-6-yl) benzamide derivatives containing a 6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinoline moiety as potent reversal agents against P …

W Xue, K Liu, T Zhang, G Dong, J Wang, J Wang… - European Journal of …, 2024 - Elsevier
Abstract P-glycoprotein (P-gp) is an important factor leading to multidrug resistance (MDR)
in cancer treatment. The co-administration of anticancer drugs and P-gp inhibitors has been …